United States (US) Biosimilar Monoclonal Antibody Market (2025-2031) | Share, Companies, Growth, Industry, Outlook, Analysis, Competitive Landscape, Size & Revenue, Forecast, Trends, Segmentation, Value
Market Forecast By Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), By Indication (Oncology, Autoimmune diseases, Others), By End User (Hospitals, Cancer treatment centers, Others) And Competitive Landscape
| Product Code: ETC9960877 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Key Highlights of the Report:
- United States (US) Biosimilar Monoclonal Antibody Market Outlook
- Market Size of United States (US) Biosimilar Monoclonal Antibody Market, 2024
- Forecast of United States (US) Biosimilar Monoclonal Antibody Market, 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Revenues & Volume for the Period 2021- 2031
- United States (US) Biosimilar Monoclonal Antibody Market Trend Evolution
- United States (US) Biosimilar Monoclonal Antibody Market Drivers and Challenges
- United States (US) Biosimilar Monoclonal Antibody Price Trends
- United States (US) Biosimilar Monoclonal Antibody Porter's Five Forces
- United States (US) Biosimilar Monoclonal Antibody Industry Life Cycle
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Adalimumab for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Bevacizumab for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Infliximab for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Rituximab for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Trastuzumab for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Indication for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Oncology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Autoimmune diseases for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By End User for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Hospitals for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Cancer treatment centers for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
- United States (US) Biosimilar Monoclonal Antibody Import Export Trade Statistics
- Market Opportunity Assessment By Type
- Market Opportunity Assessment By Indication
- Market Opportunity Assessment By End User
- United States (US) Biosimilar Monoclonal Antibody Top Companies Market Share
- United States (US) Biosimilar Monoclonal Antibody Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Biosimilar Monoclonal Antibody Company Profiles
- United States (US) Biosimilar Monoclonal Antibody Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the United States (US) Biosimilar Monoclonal Antibody Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Biosimilar Monoclonal Antibody Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Biosimilar Monoclonal Antibody Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Biosimilar Monoclonal Antibody Market - Industry Life Cycle |
3.4 United States (US) Biosimilar Monoclonal Antibody Market - Porter's Five Forces |
3.5 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Biosimilar Monoclonal Antibody Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring monoclonal antibody treatments |
4.2.2 Rising healthcare costs driving demand for more affordable treatment options |
4.2.3 Favorable regulatory environment promoting the development and approval of biosimilars |
4.3 Market Restraints |
4.3.1 High development costs and complex manufacturing processes leading to limited cost savings |
4.3.2 Patent protection and market exclusivity of originator biologics hindering biosimilar market penetration |
5 United States (US) Biosimilar Monoclonal Antibody Market Trends |
6 United States (US) Biosimilar Monoclonal Antibody Market, By Types |
6.1 United States (US) Biosimilar Monoclonal Antibody Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Adalimumab, 2021- 2031F |
6.1.4 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Bevacizumab, 2021- 2031F |
6.1.5 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Infliximab, 2021- 2031F |
6.1.6 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Rituximab, 2021- 2031F |
6.1.7 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Trastuzumab, 2021- 2031F |
6.1.8 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Biosimilar Monoclonal Antibody Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Autoimmune diseases, 2021- 2031F |
6.2.4 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Biosimilar Monoclonal Antibody Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Cancer treatment centers, 2021- 2031F |
6.3.4 United States (US) Biosimilar Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Biosimilar Monoclonal Antibody Market Import-Export Trade Statistics |
7.1 United States (US) Biosimilar Monoclonal Antibody Market Export to Major Countries |
7.2 United States (US) Biosimilar Monoclonal Antibody Market Imports from Major Countries |
8 United States (US) Biosimilar Monoclonal Antibody Market Key Performance Indicators |
8.1 Number of approved biosimilar monoclonal antibodies in the US market |
8.2 Average selling price of biosimilar monoclonal antibodies compared to originator biologics |
8.3 Market acceptance and adoption rate of biosimilar monoclonal antibodies as a percentage of total monoclonal antibody prescriptions |
9 United States (US) Biosimilar Monoclonal Antibody Market - Opportunity Assessment |
9.1 United States (US) Biosimilar Monoclonal Antibody Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Biosimilar Monoclonal Antibody Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 United States (US) Biosimilar Monoclonal Antibody Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Biosimilar Monoclonal Antibody Market - Competitive Landscape |
10.1 United States (US) Biosimilar Monoclonal Antibody Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Biosimilar Monoclonal Antibody Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Search
Thought Leadership and Analyst Meet
Our Clients
Related Reports
- Canada Oil and Gas Market (2026-2032) | Share, Segmentation, Value, Industry, Trends, Forecast, Analysis, Size & Revenue, Growth, Competitive Landscape, Outlook, Companies
- Germany Breakfast Food Market (2026-2032) | Industry, Share, Growth, Size, Companies, Value, Analysis, Revenue, Trends, Forecast & Outlook
- Australia Briquette Market (2025-2031) | Growth, Size, Revenue, Forecast, Analysis, Trends, Value, Share, Industry & Companies
- Vietnam System Integrator Market (2025-2031) | Size, Companies, Analysis, Industry, Value, Forecast, Growth, Trends, Revenue & Share
- ASEAN and Thailand Brain Health Supplements Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- ASEAN Bearings Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Europe Flooring Market (2025-2031) | Outlook, Share, Industry, Trends, Forecast, Companies, Revenue, Size, Analysis, Growth & Value
- Saudi Arabia Manlift Market (2025-2031) | Outlook, Size, Growth, Trends, Companies, Industry, Revenue, Value, Share, Forecast & Analysis
- Uganda Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Rwanda Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
Industry Events and Analyst Meet
Stationery & Paper Expo Saudi Arabia 2026
Kids & Toys Expo Saudi Arabia 2026
Gifts & Homeware Expo Saudi Arabia 2026
Smart Home Expo 2026
Industrial Facilities Management Expo 2025
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
6WResearch In News
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
- Video call with a traditional healer? Once unthinkable, it’s now common in South Africa
- Intelligent Buildings To Smooth GCC’s Path To Net Zero
